Drug Profile
Research programme: ion channel modulators - Grunenthal/Xention
Alternative Names: Ion channel programme - GrunenthalLatest Information Update: 19 Oct 2022
Price :
$50
*
At a glance
- Originator Grunenthal; Xention
- Class Small molecules
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Pain
Most Recent Events
- 19 Oct 2022 Early research in Pain is still ongoing in United Kingdom (unspecified rout) (Grunenthal pipeline, October 2022)
- 16 Jul 2016 No recent reports of development identified for research development in Pain in United Kingdom
- 15 Feb 2011 Early research in Pain in United Kingdom (unspecified route)